ClinicalTrials.gg

Program

MG-K10 Humanized Monoclonal Antibody Injection

Also written as “MG-K10 humanized monoclonal antibody injection”.

Its studies are mostly in Dermatitis, Atopic · Chronic Urticaria, led by Shanghai Mabgeek Biotech..

Furthest: phase 3, since Mar 11, 20263 company-led studies, 3 open or runningNext primary completion: Dec 2027 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Shanghai Mabgeek Biotech.33 open or runningphase 3since Mar 11, 2026Mar 11, 2026Dec 2027phase 2 · NCT07938606

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Mar 11, 2026First studies: 2 phase 3 studiesFirst studyNCT07479615, NCT07546487
  2. Oct 27, 2026Phase 2 study in Dermatitis, AtopicNCT07938606 · 24 planned · China

Ahead

  1. Dec 2027Primary completion: phase 2 study in Dermatitis, AtopicNCT07938606
  2. Mar 31, 2028Primary completion: phase 3 study in Chronic UrticariaNCT07546487
  3. Jan 2029Primary completion: phase 3 study in Dermatitis, AtopicNCT07479615

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 3 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07938606Dermatitis, Atopic · China2Not yet recruitingDec 202724
NCT07546487Chronic Urticaria3Not yet recruitingMar 31, 2028226
NCT07479615Dermatitis, Atopic3Not yet recruitingJan 2029498

How it is read

Names in the registry

  • “MG-K10 Humanized Monoclonal Antibody Injection”, 2 entries
  • “MG-K10 humanized monoclonal antibody injection”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.